SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ATIS is on the move!
ATIS 0.1000-47.4%Apr 14 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Marshall Teitelbaum who wrote (1211)12/9/1997 10:15:00 PM
From: WWS  Read Replies (1) of 2205
 
Marshall, As you do, I like to think that ATIS is a leader of the "skins" due to having aggressively pursued FDA approval for multiple indications: full and partial burns as well as diabetic foot ulcers. The fact that IART has pursued a more narrow niche (full-thickness burns) may help explain why their stock has lost 75% of its value in the past year. Bill (p.s. haven't heard about your "boards" results--ok, I hope).
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext